Skip to main content
. 2011 Jul 18;52(5):779–786. doi: 10.3349/ymj.2011.52.5.779

Table 2.

Univariate Study of Risk Factors for Chronic GvHD Incidence

graphic file with name ymj-52-779-i002.jpg

GvHD, graft-versus-host disease; BM, bone marrow; PBSC, peripheral blood stem cell; TBI, total body irradiation; CS, cyclosporine; MTX, methotrexate.

*cyclosporine+4 scheduled doses of mini-methotrexate.

cyclosporine alone, or less than 4 scheduled doses of mini-methotrexate.

Match of HLA-C at the allele level.